WHO Immunization Implementation Guide
0.1.0 - CI Build
WHO Immunization Implementation Guide
0.1.0 - CI Build
WHO Immunization Implementation Guide, published by World Health Organization (WHO). This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations and changes regularly. See the Directory of published versions
| Official URL: http://fhir.org/guides/who/smart-immunization/Measure/IMMZIND30 | Version: 0.1.0 | |||
| Draft as of 2022-05-12 | Computable Name: IMMZIND30 | |||
Clinics should report adverse events (reported and confirmed) to the central authority.
This should be tracked as an aggregate tally (which should indicate the severity, and optionally the manifestation such as rash, vomiting, etc.), with severe cases being reported using case reporting forms, and should include an analysis of whether the AEFI was a direct result (confirmed) of vaccination or not (suspected). Serious cases are those which involved hospitalization, disability, or death.
Investigation of AEFI events can lead to withdrawal of the vaccine from the market, or inform further guidance on administration of a particular antigen/product.
Resource Measure "IMMZIND30"
Profile: http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-measure-cqfm
url: http://fhir.org/guides/who/smart-immunization/Measure/IMMZIND30
version: 0.1.0
name: IMMZIND30
title: IMMZ.IND.30 Adverse Event Following Immunization (AEFI) case rate.
status: draft
date: 2022-05-12 15:36:35-0400
publisher: World Health Organization (WHO)
description: Clinics should report adverse events (reported and confirmed) to the central authority. This should be tracked as an aggregate tally (which should indicate the severity, and optionally the manifestation such as rash, vomiting, etc.), with severe cases being reported using case reporting forms, and should include an analysis of whether the AEFI was a direct result (confirmed) of vaccination or not (suspected). Serious cases are those which involved hospitalization, disability, or death. Investigation of AEFI events can lead to withdrawal of the vaccine from the market, or inform further guidance on administration of a particular antigen/product.
jurisdiction: Global (Whole world) (m49.htm#001)
library: IMMZIND30
scoring: Proportion (MeasureScoring#proportion)
type: Process (MeasureType#process)
improvementNotation: Increased score indicates improvement (MeasureImprovementNotation#increase)
group
id
IMMZIND30population
id
numeratorcode: Numerator (MeasurePopulationType#numerator)
description: Number of persons which have received a vaccine dose, and have reported an adverse event
Criteria
- Language Expression * text/cql numerator population
id
denominatorcode: Denominator (MeasurePopulationType#denominator)
description: The total number of doses administered to patients of the product.
Criteria
- Language Expression * text/cql denominator stratifier
id
vaccine-stratifierCriteria
- Language Expression * text/cql Vaccine Stratifier stratifier
id
product/manufacturer-stratifierCriteria
- Language Expression * text/cql Product/Manufacturer Stratifier stratifier
id
severity-stratifierCriteria
- Language Expression * text/cql Severity Stratifier stratifier
id
geographic-region-stratifierCriteria
- Language Expression * text/cql Geographic Region Stratifier stratifier
id
manifestation-/-event-stratifierCriteria
- Language Expression * text/cql Manifestation / Event Stratifier stratifier
id
-stratifierCriteria
- Language Expression * text/cql Stratifier